EUVIMEDEUVIMED entdecken
Crossref

We will not have to wait—building regulatory confidence in early endpoints for high-risk breast cancer

Keli Santos-Parker, Laura Esserman

AME Clinical Trials Review · 2026-06 · 4 · 28-28

DOI: 10.21037/actr-25-123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-06. Verfasst von Keli Santos-Parker und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Santos-Parker, K., & Esserman, L. (2026). We will not have to wait—building regulatory confidence in early endpoints for high-risk breast cancer. AME Clinical Trials Review, 4, 28-28. https://doi.org/10.21037/actr-25-123

Vancouver

Santos-Parker K, Esserman L. We will not have to wait—building regulatory confidence in early endpoints for high-risk breast cancer. AME Clinical Trials Review. 2026;4:28-28. doi:10.21037/actr-25-123

BibTeX
@article{SantosParker2026,
  author = {Santos-Parker, Keli and Esserman, Laura},
  title = {We will not have to wait—building regulatory confidence in early endpoints for high-risk breast cancer},
  journal = {AME Clinical Trials Review},
  year = {2026},
  volume = {4},
  pages = {28--28},
  doi = {10.21037/actr-25-123}
}
Kostenlos starten →